Anthropic Acquires AI Biotech Startup Coefficient Bio for $400 Million
What happened
On April 3, 2026, Anthropic acquired stealth AI biotech startup Coefficient Bio for over $400 million in an all-stock deal.
The Context
- Strategic Expansion: Anthropic integrates Coefficient Bio's team into its Health Care Life Sciences group to enhance drug discovery and biological research.
- Talent Acquisition: The acquisition brings in about 10 former Genentech computational biologists, bolstering Anthropic’s capabilities in a competitive market.
- Market Positioning: This move positions Anthropic against rivals like Google DeepMind, emphasizing its commitment to high-margin life sciences.
The Number
— This valuation reflects a remarkable per-employee value of approximately $40 million, underscoring the high stakes in AI-driven biotech innovation.
Takeaway
Expect Anthropic to leverage this acquisition to accelerate advancements in AI applications for drug discovery, potentially reshaping the biotech landscape.
Startup news with frequent AI coverage.
"Covers launches, funding, and product updates in AI."
— A47 Editor
Anthropic buys biotech startup Coefficient Bio in $400M deal: Reports
Anthropic has acquired the biotech startup Coefficient Bio in a stock deal valued at approximately $400 million, as reported by The Information and Eric Newcomer. Coefficient Bio specializes in developing platforms that enable artificial intelligence...
Opinionated AI coverage for general audiences.
"TNW’s AI vertical covering tools, ethics, and trends."
— A47 Editor
Anthropic just paid $400 million for a startup with fewer than 10 people
Anthropic has acquired Coefficient Bio, a stealth biotech AI startup founded just eight months ago, in an all-stock deal valued at over $400 million. This acquisition brings a team of fewer than 10 researchers, primarily former Genentech employees, i...
Curated tech headlines including AI stories.
"Influential aggregator surfacing the day’s top tech/AI links."
— A47 Editor
Source: Anthropic has acquired Coefficient Bio, which was developing a platform that enables AI to run biotech tasks such as planning drug research, for ~$400M (The Information)
Anthropic has acquired Coefficient Bio for approximately $400 million, a startup focused on developing a platform that allows artificial intelligence to perform various biotech tasks, including drug research planning. This acquisition is part of Anth...